Dr. Anil Veluvolu, MD
- Medicare services, 2024
- 3,196
- Medicare patients, 2024
- 725
- Part D claims, 2024
- 2,631
- Publications
- 1
- MIPS score, 2024
- 92
- Practice address
- 2600 Kings Hwy, Shreveport, LA 71103
- Practice phone
- Call (318) 212-8620
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
WK Hematology Oncology Associates
Shreveport, Louisiana
Find Dr. Veluvolu's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Anil Veluvolu is a hematologist and oncologist in Shreveport, Louisiana
Dr. Veluvolu practices at WK Hematology Oncology Associates in Shreveport, Louisiana.
Dr. Veluvolu's NPI, 1124174644, was assigned on January 26, 2007. Dr. Veluvolu graduated from Louisiana State University School of Medicine in New Orleans in 1999. Dr. Veluvolu holds Louisiana license 025566.
- NPI
- 1124174644NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8527007384
- NPI enumeration date
- January 26, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (318) 212-8620
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 53
- Medical school graduation
- 1999
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Anil Veluvolu practices at WK Hematology Oncology Associates in Shreveport, Louisiana
Dr. Veluvolu's primary practice is WK Hematology Oncology Associates, at 2600 Kings Hwy, Shreveport, LA 71103 in Caddo Parish. The practice phone is (318) 212-8620.
- WK Hematology Oncology Associates2600 Kings Hwy, Shreveport, LA 71103 · Caddo ParishPhone(318) 212-8620
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Anil Veluvolu is affiliated with 5 sites of care and 1 medical group
Dr. Veluvolu's primary practice is WK Hematology Oncology Associates in Shreveport, Louisiana. Dr. Veluvolu is also affiliated with Willis Knighton North. The medical group on file is Willis Knighton Genetics. Dmand AI also links Dr. Veluvolu to 2 more hospitals and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Anil Veluvolu's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Veluvolu practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| WK Hematology Oncology Associates | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Anil Veluvolu is one of 171 hematologists and oncologists in Louisiana
Hematology and oncology is Dr. Veluvolu's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Veluvolu is licensed in Louisiana.
Specialties and state licenses
- Hematology and oncology, LouisianaPrimary
Clinical focus
Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Veluvolu treats.
Hematologists and oncologists near Dr. Veluvolu
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Anil Veluvolu billed Medicare for 3,196 services in 2024
CMS data shows 3,196 Medicare services from Dr. Veluvolu across 5 procedure codes in 2024, for 725 Medicare patients. Medicare paid $243,820 for them.
Dr. Veluvolu's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3,3972024: 3,1966%
Where Dr. Veluvolu's Medicare services took place, 2024
- In an office893%
- In a facility3,10797%
Dr. Veluvolu compared with the Louisiana median for hematologists and oncologists, 2024
- Dr. Veluvolu
- Louisiana median
- Medicare services
- 3,196vs 5525.8 times
- Medicare patients
- 725vs 1843.9 times
- Part D claims
- 2,290vs 6033.8 times
Medians across 174 hematologists and oncologists in Louisiana with Dmand AI profiles that report each measure.
Dr. Veluvolu's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Veluvolu?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Veluvolu and other hematologists and oncologists in Louisiana.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Anil Veluvolu treated 725 Medicare patients in 2024, average age 74
CMS counts 725 Medicare patients who saw Dr. Veluvolu in 2024. The largest group is 65 to 74, with 320 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Veluvolu's median patient age at 71, with 55% women.
Dr. Veluvolu's Medicare patients by age, 2024
Dr. Veluvolu's Medicare patients by sex, 2024
- Women38753%
- Men33847%
Chronic conditions among Dr. Veluvolu's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis61%
- Cancer45%
- Ischemic heart disease41%
- Diabetes40%
- Chronic kidney disease35%
- Anxiety30%
Share of Medicare patients with each condition. A patient can have several.
Dr. Veluvolu's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women55%
- Men43%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Anil Veluvolu wrote 2,631 Medicare Part D claims in 2024
In 2024, Dr. Veluvolu wrote 2,631 Medicare Part D claims for 362 patients. 78% of them were for generic drugs. CMS names the drug for 2,290 of them, across 46 drugs with 11 or more claims each, at $3,832,242 in total drug cost. In 2023, CMS named 2,127 claims across 42 drugs.
Dr. Veluvolu's Part D claims by kind of drug, 2024
- Generic2,056 claims78%
- Brand-name575 claims22%
Dr. Veluvolu's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Veluvolu's Part D claims, 2024
- Opioids11%294 of 2,631 claims
- Antibiotics5%141 of 2,631 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2,1272024: 2,2908%
Drugs named by CMS: 46 in 2024, 42 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Anil Veluvolu scored 92 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Veluvolu for performance year 2024, reported through an alternative payment model (APM). Dr. Veluvolu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Veluvolu's MIPS scores, performance year 2024
- 92of 100Final score
- 81.4of 100Quality
- 95of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Anil Veluvolu has 1 publication on record
Dmand AI links 1 paper to Dr. Veluvolu in 2025. Dr. Veluvolu's most frequent co-author is Joseph Patrick Erinjeri, MD, PhD.
Dr. Veluvolu's most frequent co-authors
Recent publications by Dr. Veluvolu
See who Dr. Veluvolu researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Veluvolu works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Anil Veluvolu received $9,446 in industry payments from 2016 to 2025
CMS Open Payments shows 168 general payments to Dr. Veluvolu from 34 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Novocure Inc. paid the most, $3,406.
General payments to Dr. Veluvolu by program year, 2016 to 2025
General payments to Dr. Veluvolu by kind, 2016 to 2025
- Consulting fees$5,22655%
- Food and beverage$3,09333%
- Travel and lodging$91910%
- Education$2082%
Companies that paid Dr. Veluvolu the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Anil Veluvolu graduated from Louisiana State University School of Medicine in New Orleans
Dr. Veluvolu graduated from Louisiana State University School of Medicine in New Orleans in 1999.
- Medical school
Source: Dmand AI Professional Profile Data
Dr. Anil Veluvolu accepts plans from 15 insurance carriers
Dr. Veluvolu is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.
- Elevance
- Aetna
- Blue Cross Blue Shield of Michigan
- United Healthcare
- HCSC
- Alliant Health Plans
- Blue Cross Blue Shield of Massachusetts
- Humana
- +7 more carriersWith a free account
Plan types Dr. Veluvolu accepts, by number of carriers
- PPO11
- Medicare9
- HMO6
- POS6
- EPO3
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Anil Veluvolu's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Anil Veluvolu
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Anil Veluvolu's NPI number?
Dr. Anil Veluvolu's NPI number is 1124174644. It was assigned on January 26, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Anil Veluvolu?
Dr. Anil Veluvolu is a hematologist and oncologist in Shreveport, Louisiana. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Anil Veluvolu practice?
Dr. Veluvolu practices at 2600 Kings Hwy, Shreveport, LA 71103. Dr. Veluvolu's primary practice is WK Hematology Oncology Associates in Shreveport, Louisiana. Dmand AI also links Dr. Veluvolu to 2 hospitals and 1 group practice or clinic.
What is Dr. Anil Veluvolu's office phone number?
The practice phone on file for Dr. Veluvolu is (318) 212-8620.
What is Dr. Anil Veluvolu's medical license number?
Dr. Veluvolu holds Louisiana license 025566.
Which hospitals is Dr. Anil Veluvolu affiliated with?
Dr. Veluvolu is affiliated with Willis Knighton North. Dmand AI links Dr. Veluvolu to 2 more hospitals.
What medical group is Dr. Anil Veluvolu part of?
Dr. Veluvolu is linked to Willis Knighton Genetics.
Does Dr. Anil Veluvolu accept Medicare?
Yes. CMS data shows Dr. Veluvolu billed Medicare for 3,196 services in 2024, and Dr. Veluvolu accepts Medicare assignment.
What is Dr. Anil Veluvolu's MIPS score?
Dr. Veluvolu's MIPS final score for performance year 2024 is 92 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Anil Veluvolu see?
CMS counts 725 Medicare patients who saw Dr. Veluvolu in 2024, with an average age of 74.
Show 8 more questionsShow fewer questions
What services does Dr. Anil Veluvolu bill to Medicare?
In 2024, Dr. Veluvolu's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and hospital inpatient care (99233).
Where did Dr. Anil Veluvolu go to medical school?
Dr. Veluvolu graduated from Louisiana State University School of Medicine in New Orleans in 1999.
What drugs does Dr. Anil Veluvolu prescribe most?
In 2024 Medicare Part D data, Dr. Veluvolu's most prescribed drugs by claims were Letrozole, Hydrocodone-Acetaminophen and Prochlorperazine Maleate.
Has Dr. Anil Veluvolu received payments from drug or device companies?
CMS Open Payments shows $9,446 in general payments to Dr. Veluvolu from 34 companies from 2016 to 2025. The largest total came from Novocure Inc.
How long has Dr. Anil Veluvolu been practicing?
Dr. Veluvolu graduated from medical school in 1999, 27 years ago.
Does Dr. Anil Veluvolu do research?
Dmand AI links 1 publication to Dr. Veluvolu.
Who does Dr. Anil Veluvolu publish with?
Dr. Veluvolu's most frequent co-authors are Joseph Patrick Erinjeri, MD, PhD (1 shared paper).
What insurance does Dr. Anil Veluvolu accept?
Dr. Veluvolu is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Louisiana by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card